Effect of Cyclosporine and Rifampin on the Pharmacokinetics of Macitentan, a Tissue-Targeting Dual Endothelin Receptor Antagonist

Macitentan is a dual endothelin receptor antagonist under phase 3 investigation in pulmonary arterial hypertension. We investigated the effect of cyclosporine (Cs) and rifampin on the pharmacokinetics of macitentan and its metabolites ACT-132577 and ACT-373898 in healthy male subjects. In addition,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruderer, Shirin, Äänismaa, Päivi, Homery, Marie-Claude, Häusler, Stephanie, Landskroner, Kyle, Sidharta, Patricia N., Treiber, Alexander, Dingemanse, Jasper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282010/
https://www.ncbi.nlm.nih.gov/pubmed/22189899
http://dx.doi.org/10.1208/s12248-011-9316-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282010/
https://www.ncbi.nlm.nih.gov/pubmed/22189899
http://dx.doi.org/10.1208/s12248-011-9316-3

Ejemplares similares